TY  - GEN
AU  - Akiyama,Yukinori
AU  - Kimura,Yuusuke
AU  - Enatsu,Rei
AU  - Mikami,Takeshi
AU  - Wanibuchi,Masahiko
AU  - Mikuni,Nobuhiro
TI  - Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience
SN  - 1878-8769
PY  - 2018///0605
KW  - Adult
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bevacizumab
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Carmustine
KW  - Combined Modality Therapy
KW  - Cranial Irradiation
KW  - adverse effects
KW  - Craniotomy
KW  - Cysts
KW  - etiology
KW  - Dacarbazine
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Drug Evaluation
KW  - Drug Implants
KW  - Drug Synergism
KW  - Female
KW  - Follow-Up Studies
KW  - Glioblastoma
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - surgery
KW  - Neurosurgical Procedures
KW  - Postoperative Hemorrhage
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Temozolomide
KW  - Treatment Outcome
KW  - Tumor Microenvironment
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1016/j.wneu.2018.02.070
ER  -